Together with a group of Oxford researchers, Mark Coles, Professor of Immunology at the Kennedy Institute, will co-lead the Enabling Next-generation AI for a Bioscience-Led Economy (ENAIBLE) initiative.
A study published recently in The Lancet Psychiatry has unveiled a new approach to identifying individuals at risk of developing psychotic disorders or bipolar disorder.
A landmark international research collaboration has launched the largest clinical trial ever conducted to test therapeutics for moderate-severe dengue, a mosquito-borne viral disease that continues to spread rapidly driven by climate change and globalisation.
The Ministry of Health of Brazil and Oxford\u2019s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.
GP tutors from across the region gathered at St Hilda\u2019s College for the 2025 Nuffield Department of Primary Care Health Sciences GP Tutors Conference, exploring how connected practice can support flourishing and innovation in primary care education.
Oxford researchers have welcomed the UK government\u2019s new AI for Science Strategy, which sets out an ambitious plan to harness artificial intelligence, sovereign supercomputing and high-quality scientific data to accelerate discovery in the life sciences.
Scientists from across Oxford have identified a key set of symptoms and developed a scoring system to help clinicians in frontline medical and mental health services consider the possibility of a rare form of encephalitis, which can sometimes be mistaken for psychosis.
A ground-breaking new study aims to transform postpartum mental health care for mothers from ethnic minority backgrounds or those living in deprived areas who experience severe mental illness.
Scientists at the Centre for Medicines Discovery, part of Oxford University\u2019s Nuffield Department of Medicine, have developed a biosensor that, for the first time, allows researchers to directly measure how experimental cancer drugs engage their target inside living cells dependent on co-factors and metabolites.
The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration which includes world-leading researchers from the Kennedy Institute.
Today, on the 80-year anniversary of the Nobel Prize being awarded for the discovery and development of penicillin, Dr Alistair Farley, Scientific Lead at the Ineos Oxford Institute for antimicrobial research (IOI), urges that the collaboration behind this achievement is channelled again today to address one of the greatest global medical challenges of our time.
An international study has identified a blood-based indicator of intestinal damage and inflammation that strongly predicts mortality in sick children. The new biomarker could help to identify those children at greatest risk of dying after hospitalisation in parts of the world with limited resources.
A collaborative study, which includes contributions from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) researchers Aaron Crowther and supervisor Dario Carugo, explores new ways to model bladder biology and infection, allowing evaluation of antimicrobial therapies under physiologically relevant conditions.
Eleven academics from the University of Oxford are to lead new research projects supported by European Research Council (ERC) Consolidator Grants. These grants support highly promising mid-career scientists of any nationality and any field with building a research team at an eligible host organisation.
Dr Stuart Faulkner represented the Chevening Health Reform Fellowship at the inaugural Chevening Health Research Forum (CHERF) in China, an event jointly hosted by the UK government, the University of Oxford, and the British Chamber of Commerce in China. The forum brought together leading academics and policy specialists to strengthen UK\u2013China collaboration on health reform and showcase research supported by the Fellowship Programme.
The first volunteer has received a dose in a first-in-human trial of Oxford\u2019s Lassa vaccine, marking a major milestone in the fight against the deadly virus.
Researchers at the University of Oxford and their collaborators have demonstrated that simple, rapid, and inexpensive tests can detect deadly contaminants in medicinal syrups - contaminants that have tragically led to the deaths of hundreds of children worldwide.
A pilot study of more than 15,000 teenagers gives a complex picture of adolescent mental health, finding associations between wellbeing and factors such as sleep, vaping and exercise.
![\"Patients](\"https://www.medsci.ox.ac.uk/news/kennedy-researchers-contribute-to-uk-wide-ai-and-bioscience-training-initiative/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n